Skip to main content
MMSI logo

MMSI · Merit Medical Systems Inc · Documents

Track MMSI — free
Market Cap
$5.19B
Shares
59.92M
Volume · Nov 16 61K Avg daily vol (3M) 669.51K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2025 Revenue $1.52B up 11.8% 10-K filed Feb 24, 2026 Quarterly report FY2026 Q3 Revenue $416.24M up 8.4% 10-Q filed Oct 29, 2026 Latest results 9% organic growth, raised guidance, Solo Pace acquisition 8-K filed Oct 29, 2026 Earnings call Q2 2026 earnings call Held Jul 30, 2026
2026
Oct 29
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Quarterly report for FY2026 Q3

Merit reported nine-month sales of $1,217.0 million, up 8.5%, and net income of $122.1 million versus $90.5 million; third-quarter sales rose 8.4% to $416.2 million, and cash, cash equivalents and restricted cash totaled $505.8 million.

Revenue $416.24M ▲ 8.4% Net income $42.31M ▲ 52.4% Diluted EPS $0.70 ▲ 52.2%
Read from the MD&A section
Oct 29
Current report 8-K
9% organic growth, raised guidance, Solo Pace acquisition

Merit Medical Systems, Inc. reported third-quarter revenue of $416.2 million, up 8.4%, with 9% organic constant-currency growth, and raised 2026 guidance. It also acquired Solo Pace on October 13, 2026 for approximately $45 million in cash.

Financial results, Regulation FD disclosure Read from the first part of this long document
6 source passages
Merit Medical Systems, Inc. (NASDAQ: MMSI) Reported revenue of $416.2 million, up 8.4% Constant currency revenue\* and constant currency revenue, organic\* up 8% and up 9%, respectively We have raised our 2026 revenue and non-GAAP earnings per share guidance Merit paid cash of approximately $45 million to acquire the outstanding equity interests of Solo Pace. on October 13, 2026 Open the document at this passage
Jul 30
Quarterly report 10-Q FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2 AI summary on its way
Revenue $418.84M ▲ 9.5% Net income $38.8M ▲ 19.1% Diluted EPS $0.65 ▲ 20.4%
Apr 30
Quarterly report 10-Q FY2026 Q1, ended Mar 31
Quarterly report for FY2026 Q1 AI summary on its way
Revenue $381.88M ▲ 7.5% Net income $41M ▲ 36.0% Diluted EPS $0.68 ▲ 38.8%
Mar 31
Proxy statement DEF 14A Meeting May 13, 2026
Proxy statement AI summary on its way
Feb 24
Annual report 10-K FY2025, ended Dec 31
Annual report for FY2025 AI summary on its way
Revenue $1.52B ▲ 11.8% Net income $128.49M ▲ 6.8% Diluted EPS $2.13 ▲ 4.9%
2025
Oct 30
Quarterly report 10-Q FY2025 Q3, ended Sep 30
Quarterly report for FY2025 Q3
Revenue $384.16M ▲ 13.0% Net income $27.76M ▼ 2.4% Diluted EPS $0.46 ▼ 4.2%
Jul 30
Quarterly report 10-Q FY2025 Q2, ended Jun 30
Quarterly report for FY2025 Q2
Revenue $382.46M ▲ 13.2% Net income $32.58M ▼ 8.8% Diluted EPS $0.54 ▼ 11.5%
Apr 24
Quarterly report 10-Q FY2025 Q1, ended Mar 31
Quarterly report for FY2025 Q1
Revenue $355.35M ▲ 9.8% Net income $30.15M ▲ 6.8% Diluted EPS $0.49 ▲ 2.1%
Feb 25
Annual report 10-K FY2024, ended Dec 31
Annual report for FY2024
Revenue $1.36B ▲ 7.9% Net income $120.36M ▲ 27.5% Diluted EPS $2.03 ▲ 25.3%
2024
Showing 1–50 of 151 documents
Key facts CIK 856982 CUSIP 589889104 13F (30d) 339 filings 302 filers Visit website Investor relations